Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
7.2M
-
Shares change
-
-2.04M
-
Total reported value, excl. options
-
$59.5M
-
Value change
-
-$18.5M
-
Put/Call ratio
-
2.02
-
Number of buys
-
37
-
Number of sells
-
-56
-
Price
-
$8.25
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q2 2021
120 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q2 2021.
Co-Diagnostics, Inc. - Common Stock (CODX) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.2M shares
of 38.5M outstanding shares and own 18.69% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.85M shares), BlackRock Inc. (518K shares), Parametric Portfolio Associates LLC (490K shares), MILLENNIUM MANAGEMENT LLC (447K shares), Advisor Resource Council (276K shares), Russell Investments Group, Ltd. (254K shares), GEODE CAPITAL MANAGEMENT, LLC (238K shares), CITADEL ADVISORS LLC (225K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (192K shares), and Bank of New York Mellon Corp (148K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.